BridgeBio Pharma (NASDAQ:BBIO) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen downgraded shares of BridgeBio Pharma (NASDAQ:BBIO – Free Report) from a hold rating to a sell rating in a research note published on Friday morning. Other equities research analysts have also recently issued reports about the company. HC Wainwright lifted their price objective on BridgeBio Pharma from $49.00 to $53.00 and gave […]
Wall Street Zen downgraded shares of BridgeBio Pharma (NASDAQ:BBIO – Free Report) from a hold rating to a sell rating in a research note published on Friday morning. Other equities research analysts have also recently issued reports about the company. HC Wainwright lifted their price objective on BridgeBio Pharma from $49.00 to $53.00 and gave […]
